Differences in Treatment Outcomes Depending on the Adjuvant Treatment Modality in Craniopharyngioma
Adjuvant fractionated EBRT could be effective in controlling local failure, especially in patients with non-GTR, while maintaining acceptable treatment-related toxicity.
Authors
- Jong Hee Chang (ORCID: https://orcid.org/0000-0003-1509-9800)
- Jaeho Cho (ORCID: https://orcid.org/0000-0001-9966-5157)
- Chang‐Ok Suh (ORCID: https://orcid.org/0000-0002-3375-7072)
- Yae Won Park (ORCID: https://orcid.org/0000-0001-8907-5401)
- Byung Min Lee (ORCID: https://orcid.org/0000-0002-5970-9773)
- Eui Hyun Kim (ORCID: https://orcid.org/0000-0002-2523-7122)
- Sung Soo Ahn (ORCID: https://orcid.org/0000-0002-0503-5558)
- Ju Hyung Moon (ORCID: https://orcid.org/0000-0002-8925-5821)
- Seok‐Gu Kang (ORCID: https://orcid.org/0000-0001-5676-2037)
- Hong In Yoon (ORCID: https://orcid.org/0000-0002-2106-6856)
- Dong-Seok Kim (ORCID: https://orcid.org/0000-0001-8210-170X)
Institutions
- Yonsei University (KR)
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- CHA University Bundang Medical Center (KR)
- CHA University (KR)
Publication Details
- Journal
- Yonsei Medical Journal
- Published
- 2024-12-12
- DOI
- https://doi.org/10.3349/ymj.2023.0566
- Citations
- 2
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- National Research Foundation
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea